Immunocore

Founded in 2008, Immunocore Limited is a privately owned British clinical-stage biotechnology company. It develops biological drugs to treat cancer, infectious diseases, and autoimmune diseases using soluble T-cell receptor technology. They are headquartered in Milton, United Kingdom.